Royalty Pharma (RPRX) files to potentially sell 11.9M Class A shares

Rhea-AI Filing Summary

Royalty Pharma plc (ticker RPRX) filed notice of a proposed sale of up to 11,925,082 Class A ordinary shares through J.P. Morgan Securities LLC on NASDAQ. The shares were acquired over time, including 125,000 shares from a Conversion of LP Interests on August 7, 2026 and multiple smaller grants received as compensation from the issuer between June 30, 2021 and May 13, 2026.

Key Figures

Shares proposed to be sold: 11,925,082 Class A ordinary shares Largest single acquisition block: 125,000 Class A ordinary shares Compensation grant 05/13/2026: 7,614 Class A ordinary shares +5 more

8 metrics

Shares proposed to be sold 11,925,082 Class A ordinary shares Maximum number of Class A ordinary shares covered by this Form 144 notice

Largest single acquisition block 125,000 Class A ordinary shares Acquired on 08/07/2026 via Conversion of LP Interests

Compensation grant 05/13/2026 7,614 Class A ordinary shares Shares acquired from issuer as compensation on 05/13/2026

Compensation grant 05/12/2025 9,293 Class A ordinary shares Shares acquired from issuer as compensation on 05/12/2025

Compensation grant 06/06/2024 7,747 Class A ordinary shares Shares acquired from issuer as compensation on 06/06/2024

Compensation grant 06/30/2023 6,328 Class A ordinary shares Shares acquired from issuer as compensation on 06/30/2023

Compensation grant 06/30/2022 5,726 Class A ordinary shares Shares acquired from issuer as compensation on 06/30/2022

Compensation grant 06/30/2021 44,644 Class A ordinary shares Shares acquired from issuer as compensation on 06/30/2021

Key Terms

Form 144, Class A ordinary shares, Conversion of LP Interests, compensation

4 terms

Form 144 regulatory

"Royalty Pharma plc (ticker RPRX) filed notice of a proposed sale under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Class A ordinary shares financial

"proposed sale of up to 11,925,082 Class A ordinary shares through J.P. Morgan"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

Conversion of LP Interests financial

"125,000 shares from a Conversion of LP Interests on August 7, 2026"

compensation financial

"multiple smaller grants received as compensation from the issuer between June 30, 2021 and May 13, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 06:33 PM Accepted by SEC EDGAR 08/12/2026 - 06:32 PM Learn about SEC filing dates

FAQ

What does Royalty Pharma (RPRX) disclose in this Form 144?

Royalty Pharma discloses a proposed sale of up to 11,925,082 Class A ordinary shares on NASDAQ through J.P. Morgan Securities LLC, providing acquisition dates and reasons for how these shares were obtained.

How many Royalty Pharma (RPRX) shares are proposed to be sold?

The filing covers a proposed sale of up to 11,925,082 Class A ordinary shares. This represents the maximum number of shares that may be sold under this specific Form 144 notice.

Through which broker will the RPRX shares be sold under this notice?

The proposed sale of up to 11,925,082 Royalty Pharma Class A ordinary shares is to be executed through J.P. Morgan Securities LLC, with the shares listed for trading on NASDAQ.

How were the Royalty Pharma (RPRX) shares in this Form 144 acquired?

The shares were acquired through compensation from the issuer on several dates between 2021 and 2026 and via a Conversion of LP Interests on August 7, 2026 for 125,000 shares.

What is the largest single block of RPRX shares referenced in the acquisition history?

The largest single block listed is 125,000 Class A ordinary shares acquired on August 7, 2026 via a Conversion of LP Interests, alongside multiple smaller compensation-related share grants.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A ordinary shares	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	206352	11925082	445277344	08/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A ordinary shares	08/07/2026	Conversion of LP Interests	See "Remark"s section below			125000	08/07/2026	N/A
Class A ordinary shares	05/13/2026	Compensation	Issuer			7614	05/13/2026	N/A
Class A ordinary shares	05/12/2025	Compensation	Issuer			9293	05/12/2025	N/A
Class A ordinary shares	06/06/2024	Compensation	Issuer			7747	06/06/2024	N/A
Class A ordinary shares	06/30/2023	Compensation	Issuer			6328	06/30/2023	N/A
Class A ordinary shares	06/30/2022	Compensation	Issuer			5726	06/30/2022	N/A
Class A ordinary shares	06/30/2021	Compensation	Issuer			44644	06/30/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)